Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL2469903 | 0.84 | TSHR (0.90) | TDP1TSHRNAPRTNOTUM | |
| Pyridine SCHEMBL29006289 | 0.84 | TSHR (0.53) | TDP1TSHRNAPRT | |
| Pyridine SCHEMBL8984834 | 0.83 | — | — | |
| Pyridine SCHEMBL567569 | 0.83 | — | — | |
| Pyridine SCHEMBL6691934 | 0.83 | — | — | |
| Pyridine SCHEMBL367210 | 0.83 | — | — | |
| Pyridine SCHEMBL6466367 | 0.81 | — | — | |
| Pyridine SCHEMBL16 | 0.80 | — | — | |
| Pyridine SCHEMBL933604 | 0.80 | TSHR (1.00) | TDP1TSHRNAPRTNOTUM | |
| Pyridine SCHEMBL1654468 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY - IP SERVICES GROUP (US) | 2012-05-31 | — | — | US | claimed |
| WO-2011112514-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY (US) | 2011-09-15 | — | — | WO | claimed |
| US-20110185788-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2011-08-04 | — | — | US | claimed |
| EP-2275090-A2 | Microparticles prepared using an ionic liquid | Novartis AG (CH) | 2011-01-19 | — | — | EP | claimed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | claimed |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | AUSBORN MICHAEL | 2006-07-06 | — | — | US | claimed |
| US-20050205493-A1 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2005-09-22 | — | — | US | claimed |
| EP-1569621-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | Novartis AG (CH) | 2005-09-07 | — | — | EP | claimed |
| EP-1529205-A2 | ANALYTICAL PROCESS | Novartis AG (CH) | 2005-05-11 | — | — | EP | claimed |
| WO-2004052340-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | claimed |
| WO-2004013612-A2 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | NOVARTIS AG (CH) | 2004-02-12 | — | — | WO | claimed |
| US-5994602-A | IN THE PRESENCE OF A HYDROCARBYL ALUMINUM OR GALLIUM HALIDE AND A HYDROCARBYL-SUBSTITUTED IMIDAZOLIUM OR PYRIDINIUM HALIDE | BP CHEMICALS LIMITED (GB) | 1999-11-30 | — | — | US | claimed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | claimed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| EP-2593403-B1 | METHOD FOR PRODUCING A GEL FILM AND FILTRATION MEMBRANE PREPARED WITH THIS METHOD | UNIV MONASH (AU) | 2020-03-04 | — | — | EP | disclosed |
| EP-0558187-A1 | Butene polymers | BP Chemicals Limited (GB) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | TDP1 1587/4885TSHR 3760/4885NAPRT 4128/4885 |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | OSBPL8, OSBP, OSBP2 | TDP1 2022/4885TSHR 2589/4885NAPRT 2710/4885 |
| US-20060147532-A1 | Microparticles prepared using an ionic liquid | FIBP, MIF, CHMP4B | TDP1 1587/4885TSHR 3760/4885NAPRT 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.